Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial.

Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial.

Recent studies suggest that vitamin D deficiency represents an additional cofactor of renal anemia, with several mechanisms accounting for this relationship. In line with it, the administration of vitamin D or its analogues has been associated with an improvement of anemia. There are no data, howeve...

Full description

Bibliographic Details
Main Authors:	Eleonora Riccio, Massimo Sabbatini, Dario Bruzzese, Ivana Capuano, Silvia Migliaccio, Michele Andreucci, Antonio Pisani
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4363688?pdf=render

Similar Items

Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?
by: Antonio Pisani, et al.
Published: (2018-10-01)

Reparative effects of paricalcitol and calcitriol in patients with cardiorenal syndrome and chronic allograft nephropathy
by: A. N. Kharlamov, et al.
Published: (1970-01-01)

Comparison of the Effects of Paricalcitol and Calcitriol on Vascular Calcification in Patients Undergoing Chronic Hemodialysis
by: Süleyman Karaköse, et al.
Published: (2021-08-01)

Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis
by: Zhuolin Zhang, et al.
Published: (2021-07-01)

Successful Treatment of Severe Atopic Dermatitis with Calcitriol and Paricalcitol in an 8-Year-Old Girl
by: Christina Bothou, et al.
Published: (2018-01-01)

Cost-effectiveness analysis of paricalcitol versus calcitriol for the treatment of SHPT in dialytic patients from the SUS perspective
by: Fabiana Gatti de Menezes, et al.

Efeito do paricalcitol e do calcitriol sobre a doença cardiovascular em camundongos uninefrectomizados ApoE -/-
by: Luis Eduardo Becker
Published: (2008)

Efeito do paricalcitol e do calcitriol sobre a doença cardiovascular em camundongos uninefrectomizados ApoE -/-
by: Becker, Luis Eduardo
Published: (2008)

Vitamin D Analogues and Coronary Calcification in CKD Stages 3 and 4: A Randomized Controlled Trial of Calcitriol Versus ParicalcitolPlain-Language Summary
by: Karim H. Anis, et al.
Published: (2020-07-01)

Acute Kidney Injury by Radiographic Contrast Media: Pathogenesis and Prevention
by: Michele Andreucci, et al.
Published: (2014-01-01)

Anti-inflammatory profile of paricalcitol in kidney transplant recipients
by: Javier Donate-Correa, et al.
Published: (2017-11-01)

The potential use of biomarkers in predicting contrast-induced acute kidney injury
by: Andreucci M, et al.
Published: (2016-09-01)

Paricalcitol in management of chronic kidney disease–mineral and bone disorder
by: A. K. Eremkina, et al.
Published: (2021-04-01)

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
by: Josep M. Cruzado, et al.
Published: (2018-01-01)

Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
by: Eleonora Riccio, et al.
Published: (2020-02-01)

Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: a randomized controlled trial
by: Bhupesh Panwar, et al.
Published: (2018-02-01)

Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media
by: Ashour Michael, et al.
Published: (2014-01-01)

Paricalcitol Attenuates Contrast-Induced Acute Kidney Injury by Regulating Mitophagy and Senescence
by: Eunjin Bae, et al.
Published: (2020-01-01)

Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism
by: Francisco José Borrego Utiel, et al.
Published: (2015-07-01)

The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys
by: Yuriy Sergeevich Milovanov, et al.
Published: (2011-06-01)

Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease
by: Valentina Lorenzoni, et al.
Published: (2014-09-01)

Paricalcitol Improves Hypoxia-Induced and TGF-β1-Induced Injury in Kidney Pericytes
by: Jeong-Hoon Lim, et al.
Published: (2021-09-01)

Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease
by: Silvia Lucisano, et al.
Published: (2015-01-01)

Role of Reactive Oxygen Species in Pathogenesis of Radiocontrast-Induced Nephropathy
by: Antonio Pisani, et al.
Published: (2013-01-01)

Meta-Analysis: The Efficacy and Safety of Paricalcitol for the Treatment of Secondary Hyperparathyroidism and Proteinuria in Chronic Kidney Disease
by: Tianzhao Han, et al.
Published: (2013-01-01)

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
by: Amin Ussif, et al.
Published: (2018-08-01)

The effects of calcitriol on asthmatic mice
by: Ting Wei Chen, et al.
Published: (2016)

Inmunoregulación mediada por Calcitriol
by: Alberto Pinzón, et al.
Published: (2000-10-01)

“Calcitriol” Is Not Synonymous with “Vitamin D”
by: Samantha M. Kimball, et al.
Published: (2012-01-01)

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
by: Izquierdo María, et al.
Published: (2012-11-01)

The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism
by: Jesús Egido, et al.
Published: (2016-01-01)

Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism
by: Michalis Giakoumis, et al.
Published: (2019-03-01)

Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics
by: María Dolores Arenas Jimenez, et al.
Published: (2021-07-01)

Immunomodulatory mechanisms of action of calcitriol in psoriasis
by: Suravi Raychaudhuri, et al.
Published: (2014-01-01)

Mechanistic Effects of Calcitriol in Cancer Biology
by: Lorenza Díaz, et al.
Published: (2015-06-01)

Bisphosphonates for the Treatment of Calcitriol-Induced Hypercalcemia
by: Roselyn Cristelle Isidro Mateo, MD, MS, et al.
Published: (2019-09-01)

The Calcitriol Study : a randomised placebo controlled clinical trial to test the effects of calcitriol in steroid resistant asthma
by: Nanzer, Alexandra M.
Published: (2015)

Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis
by: Andrea W. D. Stavenuiter, et al.
Published: (2015-01-01)

Investigation of the Effect and Mechanism of Paricalcitol in Isoproterenol Induced Cardiomyopathic Rats
by: Chi-Cheng Lai, et al.
Published: (2016)

Prevention of Contrast-Induced Nephropathy through a Knowledge of Its Pathogenesis and Risk Factors
by: Michele Andreucci, et al.
Published: (2014-01-01)